Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
Study Details
Study Description
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. Interferon alfa may interfere with the growth of tumor cells. It is not yet known whether combination chemotherapy plus interleukin-2 and interferon alfa is more effective than combination chemotherapy alone for metastatic melanoma.
PURPOSE: Randomized phase III trial to compare combination chemotherapy with or without interleukin-2 and interferon alfa in treating patients who have metastatic melanoma that cannot be treated by surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
OBJECTIVES:
-
Compare response rate, duration of response, and survival rate in patients with metastatic malignant melanoma treated with cisplatin, vinblastine, and dacarbazine with or without interleukin-2 and interferon alfa-2b.
-
Determine the toxic effects of these regimens in this patient population.
OUTLINE: This is a randomized study. Patients are stratified according to performance status (0 vs 1), prior interferon (yes vs no), and number of involved sites. Patients are randomized to one of two treatment arms.
-
Arm I: Patients receive cisplatin IV over 30 minutes daily immediately followed by vinblastine IV on days 1-4. Patients also receive dacarbazine IV over 60 minutes on day 1 following vinblastine.
-
Arm II: Patients receive treatment as in arm I. Patients also receive interleukin 2 (IL-2) IV continuously on days 1-4 and interferon alfa-2b subcutaneously (SC) daily before IL-2 on days 1-4 and after IL-2 on day 5, followed by filgrastim (G-CSF) (SC) daily on days 7-16.
Treatment repeats every 3 weeks for 4 courses in the absence of disease progression or unacceptable toxicity.
Patients are followed at 6 weeks, every 3 months for 18 months, every 6 months for 18 months, and then annually for 2 years.
PROJECTED ACCRUAL: A total of 482 patients will be accrued for this study within 3.5 years.
Study Design
Outcome Measures
Primary Outcome Measures
- Overall survival []
Secondary Outcome Measures
- Response rate (complete and partial response) []
- Durable complete response rate []
- Response duration []
Eligibility Criteria
Criteria
DISEASE CHARACTERISTICS:
-
Histologically confirmed surgically incurable metastatic malignant melanoma
-
Measurable disease
-
No active brain metastases or edema
-
No leptomeningeal disease
-
No ocular melanoma
PATIENT CHARACTERISTICS:
Age:
- 18 and over
Performance status:
- ECOG 0-1
Life expectancy:
- Not specified
Hematopoietic:
-
Absolute neutrophil count at least 1,500/mm^3
-
Platelet count at least 100,000/mm^3
-
Hemoglobin at least 9 g/dL
Hepatic:
-
Bilirubin no greater than 1.5 mg/dL
-
SGOT less than 3 times the upper limit of normal unless due to liver metastases
Renal:
-
Creatinine less than 1.5 mg/dL OR
-
Creatinine clearance at least 75 mL/min
Cardiovascular:
-
No congestive heart failure
-
No symptoms of coronary artery disease
-
No serious cardiac arrhythmias
-
No prior myocardial infarction on EKG
-
Normal cardiac stress test required for the following:
-
Over 50 years of age
-
Abnormal EKG
-
Prior history of cardiac disease
Pulmonary:
-
No symptomatic pulmonary disease
-
FEV1 greater than 2.0 L OR at least 75% predicted if over 50 years of age or with history of pulmonary symptoms
Other:
-
Not pregnant or nursing
-
Negative pregnancy test
-
Fertile patients must use effective contraception
-
No significant infection
-
HIV negative
-
No other prior malignancy within the past 5 years except basal cell or squamous cell skin cancer or carcinoma in situ of the cervix
-
No organ allografts
-
No significant disease other than malignancy
-
No seizure disorder
PRIOR CONCURRENT THERAPY:
Biologic therapy:
-
No prior interleukin-2 therapy for metastatic disease
-
At least 4 weeks since prior vaccine therapy
-
At least 4 weeks since prior adjuvant immunotherapy
Chemotherapy:
- No prior chemotherapy for disease
Endocrine therapy:
- No concurrent corticosteroids
Radiotherapy:
-
No prior radiation therapy to measurable disease site unless disease is clearly progressive
-
At least 4 weeks since prior radiation therapy for local control or palliation and recovered
Surgery:
- Recovered from prior surgery
Other:
-
No prior systemic therapy for metastatic disease
-
At least 3 months since definitive therapy for brain metastases
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | MBCCOP - Gulf Coast | Mobile | Alabama | United States | 36688 |
2 | CCOP - Greater Phoenix | Phoenix | Arizona | United States | 85006-2726 |
3 | Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) | Phoenix | Arizona | United States | 85012 |
4 | Veterans Affairs Medical Center - Tucson | Tucson | Arizona | United States | 85723 |
5 | Arizona Cancer Center | Tucson | Arizona | United States | 85724 |
6 | University of Arkansas for Medical Sciences | Little Rock | Arkansas | United States | 72205 |
7 | Veterans Affairs Medical Center - Little Rock (McClellan) | Little Rock | Arkansas | United States | 72205 |
8 | Cancer Center and Beckman Research Institute, City of Hope | Duarte | California | United States | 91010-3000 |
9 | USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles | California | United States | 90033-0804 |
10 | Veterans Affairs Medical Center - West Los Angeles | Los Angeles | California | United States | 90073 |
11 | Jonsson Comprehensive Cancer Center, UCLA | Los Angeles | California | United States | 90095-1781 |
12 | Veterans Affairs Outpatient Clinic - Martinez | Martinez | California | United States | 94553 |
13 | CCOP - Bay Area Tumor Institute | Oakland | California | United States | 94609-3305 |
14 | Chao Family Comprehensive Cancer Center | Orange | California | United States | 92868 |
15 | University of California Davis Medical Center | Sacramento | California | United States | 95817 |
16 | UCSF Cancer Center and Cancer Research Institute | San Francisco | California | United States | 94143-0128 |
17 | CCOP - Santa Rosa Memorial Hospital | Santa Rosa | California | United States | 95403 |
18 | David Grant Medical Center | Travis Air Force Base | California | United States | 94535 |
19 | University of Colorado Cancer Center | Denver | Colorado | United States | 80010 |
20 | Veterans Affairs Medical Center - Denver | Denver | Colorado | United States | 80220 |
21 | CCOP - Atlanta Regional | Atlanta | Georgia | United States | 30342-1701 |
22 | Dwight David Eisenhower Army Medical Center | Fort Gordon | Georgia | United States | 30905-5650 |
23 | Cancer Research Center of Hawaii | Honolulu | Hawaii | United States | 96813-2424 |
24 | MBCCOP - University of Illinois at Chicago | Chicago | Illinois | United States | 60612-7323 |
25 | Veterans Affairs Medical Center - Chicago (Westside Hospital) | Chicago | Illinois | United States | 60612 |
26 | CCOP - Central Illinois | Decatur | Illinois | United States | 62526 |
27 | Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) | Hines | Illinois | United States | 60141 |
28 | Loyola University Medical Center | Maywood | Illinois | United States | 60153 |
29 | University of Kansas Medical Center | Kansas City | Kansas | United States | 66160-7353 |
30 | CCOP - Wichita | Wichita | Kansas | United States | 67214-3882 |
31 | Veterans Affairs Medical Center - Wichita | Wichita | Kansas | United States | 67218 |
32 | Veterans Affairs Medical Center - Lexington | Lexington | Kentucky | United States | 40502-2236 |
33 | Albert B. Chandler Medical Center, University of Kentucky | Lexington | Kentucky | United States | 40536-0084 |
34 | MBCCOP - LSU Health Sciences Center | New Orleans | Louisiana | United States | 70112 |
35 | Tulane University School of Medicine | New Orleans | Louisiana | United States | 70112 |
36 | Louisiana State University Health Sciences Center - Shreveport | Shreveport | Louisiana | United States | 71130-3932 |
37 | Veterans Affairs Medical Center - Shreveport | Shreveport | Louisiana | United States | 71130 |
38 | Boston Medical Center | Boston | Massachusetts | United States | 02118 |
39 | Veterans Affairs Medical Center - Boston (Jamaica Plain) | Jamaica Plain | Massachusetts | United States | 02130 |
40 | Veterans Affairs Medical Center - Ann Arbor | Ann Arbor | Michigan | United States | 48105 |
41 | CCOP - Ann Arbor Regional | Ann Arbor | Michigan | United States | 48106 |
42 | University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | United States | 48109-0912 |
43 | Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | United States | 48201-1379 |
44 | Veterans Affairs Medical Center - Detroit | Detroit | Michigan | United States | 48201-1932 |
45 | Henry Ford Hospital | Detroit | Michigan | United States | 48202 |
46 | Providence Hospital - Southfield | Southfield | Michigan | United States | 48075-9975 |
47 | CCOP - Duluth | Duluth | Minnesota | United States | 55805 |
48 | Veterans Affairs Medical Center - Biloxi | Biloxi | Mississippi | United States | 39531-2410 |
49 | University of Mississippi Medical Center | Jackson | Mississippi | United States | 39216-4505 |
50 | Veterans Affairs Medical Center - Jackson | Jackson | Mississippi | United States | 39216 |
51 | Keesler Medical Center - Keesler AFB | Keesler AFB | Mississippi | United States | 39534-2576 |
52 | Veterans Affairs Medical Center - Kansas City | Kansas City | Missouri | United States | 64128 |
53 | CCOP - Kansas City | Kansas City | Missouri | United States | 64131 |
54 | St. Louis University Health Sciences Center | Saint Louis | Missouri | United States | 63110 |
55 | CCOP - St. Louis-Cape Girardeau | Saint Louis | Missouri | United States | 63141 |
56 | CCOP - Cancer Research for the Ozarks | Springfield | Missouri | United States | 65807 |
57 | CCOP - Montana Cancer Consortium | Billings | Montana | United States | 59101 |
58 | Veterans Affairs Medical Center - Albuquerque | Albuquerque | New Mexico | United States | 87108-5138 |
59 | MBCCOP - University of New Mexico HSC | Albuquerque | New Mexico | United States | 87131 |
60 | Veterans Affairs Medical Center - Albany | Albany | New York | United States | 12208 |
61 | Herbert Irving Comprehensive Cancer Center | New York | New York | United States | 10032 |
62 | University of Rochester Medical Center | Rochester | New York | United States | 14642 |
63 | CCOP - Southeast Cancer Control Consortium | Winston-Salem | North Carolina | United States | 27104-4241 |
64 | Veterans Affairs Medical Center - Cincinnati | Cincinnati | Ohio | United States | 45220-2288 |
65 | Barrett Cancer Center, The University Hospital | Cincinnati | Ohio | United States | 45267-0501 |
66 | Cleveland Clinic Taussig Cancer Center | Cleveland | Ohio | United States | 44195 |
67 | CCOP - Columbus | Columbus | Ohio | United States | 43206 |
68 | Veterans Affairs Medical Center - Dayton | Dayton | Ohio | United States | 45428 |
69 | CCOP - Dayton | Kettering | Ohio | United States | 45429 |
70 | CCOP - Toledo Community Hospital Oncology Program | Toledo | Ohio | United States | 43623-3456 |
71 | Oklahoma Medical Research Foundation | Oklahoma City | Oklahoma | United States | 73104 |
72 | Veterans Affairs Medical Center - Oklahoma City | Oklahoma City | Oklahoma | United States | 73104 |
73 | Veterans Affairs Medical Center - Portland | Portland | Oregon | United States | 97207 |
74 | CCOP - Columbia River Program | Portland | Oregon | United States | 97225 |
75 | OHSU Cancer Institute | Portland | Oregon | United States | 97239 |
76 | Veterans Affairs Medical Center - Charleston | Charleston | South Carolina | United States | 29401-5799 |
77 | Medical University of South Carolina | Charleston | South Carolina | United States | 29425-0721 |
78 | CCOP - Greenville | Greenville | South Carolina | United States | 29615 |
79 | CCOP - Upstate Carolina | Spartanburg | South Carolina | United States | 29303 |
80 | Simmons Cancer Center - Dallas | Dallas | Texas | United States | 75235-8852 |
81 | Brooke Army Medical Center | Fort Sam Houston | Texas | United States | 78234-6200 |
82 | University of Texas Medical Branch | Galveston | Texas | United States | 77555-0565 |
83 | Veterans Affairs Medical Center - Houston | Houston | Texas | United States | 77030 |
84 | University of Texas Health Science Center at San Antonio | San Antonio | Texas | United States | 78284-7845 |
85 | Veterans Affairs Medical Center - San Antonio (Murphy) | San Antonio | Texas | United States | 78284 |
86 | Veterans Affairs Medical Center - Temple | Temple | Texas | United States | 76504 |
87 | CCOP - Scott and White Hospital | Temple | Texas | United States | 76508 |
88 | Huntsman Cancer Institute | Salt Lake City | Utah | United States | 84112-5550 |
89 | Veterans Affairs Medical Center - Salt Lake City | Salt Lake City | Utah | United States | 84148 |
90 | CCOP - Virginia Mason Research Center | Seattle | Washington | United States | 98101 |
91 | Swedish Cancer Institute | Seattle | Washington | United States | 98104 |
92 | Veterans Affairs Medical Center - Seattle | Seattle | Washington | United States | 98108 |
93 | CCOP - Northwest | Tacoma | Washington | United States | 98405-0986 |
94 | Madigan Army Medical Center | Tacoma | Washington | United States | 98431-5048 |
Sponsors and Collaborators
- Eastern Cooperative Oncology Group
- National Cancer Institute (NCI)
- Southwest Oncology Group
- Cancer and Leukemia Group B
Investigators
- Study Chair: Michael B. Atkins, MD, Tufts Medical Center
- Study Chair: Lawrence E. Flaherty, MD, Barbara Ann Karmanos Cancer Institute
- Study Chair: David M. Gustin, MD, University of Illinois at Chicago
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CDR0000065617
- E3695
- CLB-509802
- SWOG-E3695